Emerging Concepts on Inhibitors of Indoleamine 2,3-Dioxygenase in Rheumatic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|31|5381-5393

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.31, 2012-11, pp. : 5381-5393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 938-952

Bentham Science Publishers

Access to resources Recommend Favorite

Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases

By Tan PH   Bharath AK  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 8, 2009-08 ,pp. : 987-1012

Informa Healthcare

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 – 2012)

By Dolušić Eduard   Frédérick Raphaël  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1367-1381

Informa Healthcare

Access to resources Recommend Favorite

Biochemical Properties of Indoleamine 2,3-dioxygenase: From Structure to Optimized Design of Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2205-2214

Bentham Science Publishers

Access to resources Recommend Favorite

Marine Natural Products and Other Derivatives as Potent Indoleamine 2,3-Dioxygenase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-09 ,pp. : 988-996

Bentham Science Publishers

Access to resources Recommend Favorite